These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38938306)

  • 1. Biomarkers and Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease.
    Prescott E; Bove KB; Bechsgaard DF; Shafi BH; Lange T; Schroder J; Suhrs HE; Nielsen RL
    JACC Adv; 2023 Mar; 2(2):100264. PubMed ID: 38938306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of non-invasive myocardial work for the evaluation and prediction of coronary microvascular dysfunction in angina with no obstructive coronary artery disease.
    Li Y; Sun D; Zhao H; Qin Z; Ji W; Zhang H; Jiao N; Luan B; Ding M; Zhu F
    Front Cardiovasc Med; 2023; 10():1209122. PubMed ID: 37645517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction.
    Schroder J; Mygind ND; Frestad D; Michelsen M; Suhrs HE; Bove KB; Gustafsson I; Kastrup J; Prescott E
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100370. PubMed ID: 31193994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Endothelial Function and Coronary Flow Velocity Reserve Are Not Associated in Women with Angina and No Obstructive Coronary Artery Disease: The iPOWER Study.
    Flintholm Raft K; Frestad D; Michelsen MM; Suhrs HE; Rask AB; Nilsson M; Hermann TS; Prescott E
    J Vasc Res; 2017; 54(5):309-319. PubMed ID: 28942444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.
    Pena A; Michelsen MM; Mygind ND; Gustafsson I; Høst N; Bech J; Kastrup J; Hansen HS; Hansen PR; Prescott E
    Echocardiography; 2019 Jun; 36(6):1110-1117. PubMed ID: 31012159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms.
    Bove KB; Michelsen MM; Schroder J; Suhrs HE; Bechsgaard DF; Mygind ND; Aziz A; Kastrup J; Gustafsson I; Prescott E
    Open Heart; 2021 Jan; 8(1):. PubMed ID: 33462108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study.
    Michelsen MM; Mygind ND; Pena A; Aziz A; Frestad D; Høst N; Prescott E;
    JACC Cardiovasc Imaging; 2016 Apr; 9(4):411-7. PubMed ID: 27056160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease.
    Michelsen MM; Pena A; Mygind ND; Bech J; Gustafsson I; Kastrup J; Hansen HS; Høst N; Hansen PR; Prescott E
    Echocardiography; 2018 Feb; 35(2):196-203. PubMed ID: 29222822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy.
    Bechsgaard DF; Hove JD; Michelsen MM; Mygind ND; Pena A; Hansen PR; Hansen HS; Kastrup J; Høst N; Gustafsson I; Prescott E
    Clin Physiol Funct Imaging; 2021 Jan; 41(1):85-94. PubMed ID: 33030280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of TDI combined with 2D-STI on evaluating the microcirculation dysfunction and left ventricular dysfunction in patients with non-obstructive coronary angina].
    Liu TT; Ding MY; Sun DD; Ji W; Zhang HH; Li Y; Guo LJ; Zhu F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Dec; 49(12):1191-1197. PubMed ID: 34905896
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Schroder J; Michelsen MM; Mygind ND; Suhrs HE; Bove KB; Bechsgaard DF; Aziz A; Gustafsson I; Kastrup J; Prescott E
    Eur Heart J; 2021 Jan; 42(3):228-239. PubMed ID: 33477168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, non-endothelial dependent coronary microvascular function and diastolic function-Are they linked?
    Suhrs HE; Schroder J; Bové KB; Mygind ND; Frestad D; Michelsen MM; Lange T; Gustafsson I; Kastrup J; Prescott E
    PLoS One; 2020; 15(7):e0236035. PubMed ID: 32673354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary Microvascular Dysfunction Restored After Surgery in Inflammatory Bowel Disease: A Prospective Observational Study.
    Kakuta K; Dohi K; Yamamoto T; Fujimoto N; Shimoyama T; Umegae S; Ito M
    J Am Heart Assoc; 2021 May; 10(9):e019125. PubMed ID: 33899514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study.
    Mygind ND; Michelsen MM; Pena A; Frestad D; Dose N; Aziz A; Faber R; Høst N; Gustafsson I; Hansen PR; Hansen HS; Bairey Merz CN; Kastrup J; Prescott E
    J Am Heart Assoc; 2016 Mar; 5(3):e003064. PubMed ID: 27068634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary Artery Disease.
    Schroder J; Prescott E
    Front Cardiovasc Med; 2021; 8():723542. PubMed ID: 34778394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study.
    Mygind ND; Michelsen MM; Pena A; Qayyum AA; Frestad D; Christensen TE; Ghotbi AA; Dose N; Faber R; Vejlstrup N; Hasbak P; Kjaer A; Prescott E; Kastrup J;
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):76. PubMed ID: 27809867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary microvascular dysfunction is associated with degree of anaemia in end-stage renal disease.
    Radhakrishnan A; Pickup LC; Price AM; Law JP; McGee KC; Fabritz L; Senior R; Steeds RP; Ferro CJ; Townend JN
    BMC Cardiovasc Disord; 2021 Apr; 21(1):211. PubMed ID: 33902440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: The iPOWER study.
    Michelsen MM; Mygind ND; Pena A; Olsen RH; Christensen TE; Ghotbi AA; Hasbak P; Kjaer A; Gustafsson I; Hansen PR; Hansen HS; Høst N; Kastrup J; Prescott E
    Int J Cardiol; 2017 Feb; 228():435-443. PubMed ID: 27870973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive coronary flow velocity reserve assessment predicts adverse outcome in women with unstable angina without obstructive coronary artery stenosis.
    Montisci R; Marchetti MF; Ruscazio M; Biddau M; Secchi S; Zedda N; Casula R; Tuveri F; Kerkhof PL; Meloni L; Tona F
    J Public Health Res; 2023 Apr; 12(2):22799036231181716. PubMed ID: 37333028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of myocardial work in the estimation of left ventricular systolic function in patients with coronary microvascular disease: A study based on adenosine stress echocardiography.
    Liu Q; Li Q; Wan X; Xu M; Pan J; Zhang Y; Li M; Zhang M
    Front Cardiovasc Med; 2023; 10():1119785. PubMed ID: 37113699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.